Reid Huber

Board Observer

Partner, Third Rock Ventures

At Third Rock Ventures, Reid brings over 20 years of operating experience in the biotechnology industry to focus on the formation, development and strategy of the firm’s portfolio companies. Reid was a member of the founding scientific team at Incyte in 2002, and most recently served as the company’s executive vice president and chief scientific officer. Prior to Incyte, Reid held positions of increasing responsibility at Dupont Pharmaceuticals and Bristol-Myers Squibb.

Reid received his B.S. in molecular genetics and biochemistry from Murray State University and his Ph.D. in human molecular genetics from Washington University School of Medicine in St. Louis. He conducted his postdoctoral training at the National Institutes of Health.